{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-005802","form_type":"8-K","ticker":"ITGR","cik":"0001114483","company_name":"Integer Holdings Corp","filed_at":"2024-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.705660+00:00","generated_at":"2026-05-30T10:20:42.766363+00:00","sec_items":["2.02","7.01","5.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Integer Q3 sales +9% to $431M; raises FY outlook; promotes Khales to COO","bullets":["Q3 sales $431M (+9% YoY), organic +4%; GAAP op income $58M (+19%), adj op income $76M (+17%).","GAAP diluted EPS $1.01; adj EPS $1.43; adj EBITDA $96M (+18%).","Raises FY 2024 adj op income midpoint to $280-288M (+18-22%); FY sales $1.707-1.727B (+10-11%).","Electrochem divestiture for $50M cash on track to close October 2024.","Khales promoted to COO, Senn to President Cardio & Vascular; both effective Q1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-005802","json":"https://secwatch.observer/filing/0001171843-24-005802.json","markdown":"https://secwatch.observer/filing/0001171843-24-005802.md","text":"https://secwatch.observer/filing/0001171843-24-005802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/f8k_102424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:20:42.766363+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"436dd67ab5","claim":"Andrew Senn was appointed as President, Cardio and Vascular at Integer Holdings Corp.","evidence_excerpt":"In connection therewith, Andrew Senn, who currently serves as Senior Vice President, Strategy, Business Development and Investor Relations, has been appointed to serve as President, Cardio and Vascular.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President, Cardio and Vascular"}]},{"claim_id":"ac65ba8dda","claim":"Payman Khales changed role as Chief Operating Officer at Integer Holdings Corp.","evidence_excerpt":"On October 24, 2024, the Company announced that Payman Khales, who currently serves as the Company’s President, Cardio & Vascular, has been promoted to serve in the newly created role of Chief Operating Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"promoted"},{"label":"Role","value":"Chief Operating Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}